title: Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
abstract: Comedo-DCIS is a histologic subtype of preinvasive breast neoplasia that is characterized by prominent apoptotic cell death and has greater malignant potential than other DCIS subtypes. We investigated the mechanisms of apoptosis in comedo-DCIS and its role in conversion of comedo-DCIS to invasive cancer. Clinical comedo-DCIS excisions and the MCF10DCIS.com human breast cancer model which produces lesions resembling comedo-DCIS were analyzed. Apoptotic luminal and myoepithelial cells were identified by TUNEL and reactivity to cleaved PARP antibody and cell death assessed by Western blotting, Mitocapture and immunohistochemical assays. MCF10DCIS.com cells undergo spontaneous apoptosis in vitro, both in monolayers and multicellular spheroids; it is associated with increased mitochondrial membrane permeability, increase in Bax/Bcl-2 ratio and occurs via caspase-9-dependent p53-independent pathway. This suggests that apoptosis is stromal-independent and that the cells are programmed to undergo apoptosis. Immunostaining with cleaved PARP antibody showed that myoepithelial apoptosis occurs before lesions progress to comedo-DCIS in both clinical comedo-DCIS and in vivo MCF10DCIS.com lesions. Intense staining for MMP-2, MMP-3, MMP-9 and MMP-11 was observed in the stroma and epithelia of solid DCIS lesions prior to conversion to comedo-DCIS in clinical and MCF10DCIS.com lesions. Gelatin zymography showed higher MMP-2 levels in lysates and conditioned media of MCF10DCIS. com cells undergoing apoptosis. These data suggest that signals arising from the outside (microenvironmental) and inside (internal genetic alterations) of the duct act in concert to trigger apoptosis of myoepithelial and luminal epithelial cells. Our findings implicate spontaneous apoptosis in both the etiology and progression of comedo-DCIS. It is possible that spontaneous apoptosis facilitates elimination of cells thus permitting expansion and malignant transformation of cancer cells that are resistant to spontaneous apoptosis.
authors.affiliation: Breast Cancer Program, Karmanos Cancer Institute, Department of Pathology, Wayne State University, Detroit, Michigan, USA. shekharm@karmanos.org
authors.forename: Malathy P V
authors.initials: MP
authors.lastname: Shekhar
authors.forename: Larry
authors.initials: L
authors.lastname: Tait
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Pauley
authors.forename: Gen Sheng
authors.initials: GS
authors.lastname: Wu
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Santner
authors.forename: Pratima
authors.initials: P
authors.lastname: Nangia-Makker
authors.forename: Varun
authors.initials: V
authors.lastname: Shekhar
authors.forename: Hind
authors.initials: H
authors.lastname: Nassar
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Visscher
authors.forename: Gloria H
authors.initials: GH
authors.lastname: Heppner
authors.forename: Fred R
authors.initials: FR
authors.lastname: Miller
mesh_terms: D000818:Animals; D017209:Apoptosis; D001943:Breast Neoplasms / Q000473:pathology*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000473:pathology*; D045744:Cell Line, Tumor; D004848:Epithelium / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D007700:Kinetics; D008327:Mammography / Q000379:methods; D051379:Mice; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism
chemical_list: D011065:Poly(ADP-ribose) Polymerases
references.citation: Br J Cancer. 1998 Sep;78(6):788-94
references.pmid: 9743302
references.citation: Eur J Cancer. 1990;26(9):956-9
references.pmid: 2177615
references.citation: Mol Cell. 2003 Mar;11(3):577-90
references.pmid: 12667443
references.citation: J Biol Chem. 2002 Feb 8;277(6):4351-60
references.pmid: 11733517
references.citation: Cancer Res. 2000 Jan 15;60(2):439-49
references.pmid: 10667599
references.citation: Pathol Int. 2003 Jul;53(7):422-8
references.pmid: 12828606
references.citation: Cancer. 1996 May 1;77(9):1831-5
references.pmid: 8646681
references.citation: Ultrastruct Pathol. 2000 May-Jun;24(3):135-44
references.pmid: 10914424
references.citation: Genes Dev. 2001 Nov 15;15(22):2922-33
references.pmid: 11711427
references.citation: J Mammary Gland Biol Neoplasia. 1998 Apr;3(2):177-89
references.pmid: 10819526
references.citation: Clin Cancer Res. 2000 Dec;6(12):4823-30
references.pmid: 11156241
references.citation: Microsc Res Tech. 2002 Oct 15;59(2):92-101
references.pmid: 12373719
references.citation: Cell Biol Toxicol. 1998 Mar;14(2):121-32
references.pmid: 9553723
references.citation: J Natl Cancer Inst. 2004 Jun 16;96(12):906-20
references.pmid: 15199110
references.citation: J Cell Biochem Suppl. 1993;17G:144-52
references.pmid: 8007693
references.citation: JAMA. 1996 Mar 27;275(12):913-8
references.pmid: 8598618
references.citation: J Mammary Gland Biol Neoplasia. 2007 Mar;12(1):15-23
references.pmid: 17323120
references.citation: J Natl Cancer Inst. 2000 Jul 19;92(14):1185-6
references.pmid: 10904098
references.citation: Breast Cancer Res. 2003;5(6):R231-41
references.pmid: 14580259
references.citation: Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):30-7
references.pmid: 15722791
references.citation: Semin Cell Dev Biol. 2000 Jun;11(3):191-201
references.pmid: 10906276
references.citation: Int J Cancer. 2007 May 15;120(10):2127-34
references.pmid: 17266026
references.citation: J Biol Chem. 1998 Dec 11;273(50):33533-9
references.pmid: 9837934
references.citation: Breast Cancer Res Treat. 1986;7(3):171-80
references.pmid: 3022849
references.citation: Int J Oncol. 1996 Aug;9(2):263-7
references.pmid: 21541510
references.citation: Cancer Cell. 2008 May;13(5):394-406
references.pmid: 18455123
references.citation: Exp Cell Res. 2004 Dec 10;301(2):103-18
references.pmid: 15530847
references.citation: Cancer Res. 2002 Apr 1;62(7):2115-24
references.pmid: 11929833
references.citation: J Biol Chem. 2003 May 9;278(19):17408-20
references.pmid: 12611882
references.citation: J Theor Biol. 2005 Feb 21;232(4):523-43
references.pmid: 15588633
references.citation: J Cell Physiol. 2002 Aug;192(2):131-7
references.pmid: 12115719
references.citation: Leukemia. 2000 Sep;14(9):1695-703
references.pmid: 10995018
references.citation: Cell Death Differ. 2003 Oct;10(10):1188-203
references.pmid: 14502242
references.citation: N Engl J Med. 1988 Nov 10;319(19):1239-45
references.pmid: 2903446
references.citation: Am J Clin Pathol. 2007 Jul;128(1):86-91
references.pmid: 17580274
references.citation: Oncol Rep. 2000 May-Jun;7(3):473-8
references.pmid: 10767354
references.citation: CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
references.pmid: 17237035
references.citation: Semin Cancer Biol. 2000 Dec;10(6):415-33
references.pmid: 11170864